CURE

223de028386be82c6b70e6f13413dfbb.jpg
ETFS S&P Biotech ETF
ISIN AU0000028110

ETFS S&P Biotech ETF (CURE) aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index by holding all of the shares that make up the index closely in proportion to their index weights.

This ETF provides exposure to the US biotechnology sub-industry within the health care sector. The fund adopts an equally weighted strategy which gives higher exposure to small and mid-cap stocks held within the fund compared to market capitalisation weighted approach.

To be eligible for inclusion companies must be part of the Biotechnology sub-industry and meet minimum market capitalisation and liquidity requirements.

Insights
Product Information
Trading Information
Management & Administration
Benchmark Information
Allocation
Performance
Performance Table
Total Return (%) the FundTotal Return (%) benchmarkTracking differenceTracking error
1 Month16.54%16.66%-0.12%0.09%
3 Months19.09%19.34%-0.25%0.12%
6 Months18.45%18.77%-0.32%0.15%
1 Year22.88%23.60%-0.72%0.38%
3 Year p.a.------------
5 Year p.a.------------
10 Year p.a.------------
Since inception p.a.17.75%18.35%-0.60%0.44%

Last Updated: 06 Dec 2019

Last Updated: 06 Dec 2019

Select date

Historical Data

Pick date range to download historical data

Distributions
Investment Research
Announcements
Resources